Bulletin
Investor Alert

New York Markets After Hours

Oncolytics Biotech Inc.

TSE: CA:ONC

GO

ONC
/zigman2/quotes/203812837/delayed

$

2.26

Change

-0.09 -3.83%

Volume

Volume 90,789

Jan 27, 2022, 4:00 p.m.

Quotes are delayed by 15 min

/zigman2/quotes/203812837/delayed

Previous close

$ 2.35

$ 2.26

Change

-0.09 -3.83%

Day low

Day high

$2.22

$2.39

Open
Open: 2.39

52 week low

52 week high

$1.59

$6.06

Open

Market cap

$129.31M

Average volume

121,223

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.56

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/ca/onc

MarketWatch News on ONC

  1. Oncolytics shares rise on data from Reolysin study

    9:36 a.m. April 17, 2007

    - Gabriel Madway

  2. Oncolytics Biotech gets U.K. approval for Reolysin trial

    10:45 a.m. Jan. 3, 2007

    - Gabriel Madway

  3. Oncolytics Biotech gets U.K. approval for Reolysin trial

    10:37 a.m. Jan. 3, 2007

    - Gabriel Madway

  4. Oncolytics Biotech shares up 4.3% at $2.18

    10:38 a.m. Jan. 3, 2007

    - Gabriel Madway

  5. Oncolytics starts patient enrollment in Reolysin trial

    10:59 a.m. Dec. 22, 2006

    - Gabriel Madway

  6. Oncolytics starts patient enrollment in Reolysin trial

    10:50 a.m. Dec. 22, 2006

    - Gabriel Madway

/news/nonmarketwatch/company/ca/onc

Other News on ONC

  1. Stocks in play: Oncolytics Biotech Inc

    9:25 a.m. Today

    - Baystreet.ca

  2. Stocks in play: Oncolytics Biotech Inc

    12:07 p.m. Jan. 20, 2022

    - Baystreet.ca

  3. Stocks in play: Oncolytics Biotech Inc

    8:43 a.m. Jan. 20, 2022

    - Baystreet.ca

  4. Stocks in play: Oncolytics Biotech Inc.

    1:01 p.m. Dec. 21, 2021

    - Baystreet.ca

  5. Stocks in play: Oncolytics Biotech Inc.

    9:21 a.m. Dec. 15, 2021

    - Baystreet.ca

  6. Stocks in play: Oncolytics Biotech Inc.

    11:15 a.m. Dec. 10, 2021

    - Baystreet.ca

  7. Loading more headlines...
/news/pressrelease/company/ca/onc

Press Releases on ONC

  1. Promising Results Continue to Develop Optimism in Fight Against Cancers

    11:10 a.m. Today

    - PR Newswire - PRF

  2. Promising Results Continue to Develop Optimism in Fight Against Cancers

    11:01 a.m. Today

    - Financial News Media

  3. R&D Spending Increases Exponentially for Higher Standard of Breast Cancer Drug Treatments

    8:35 a.m. Today

    - Financial News Media

  4. R&D Spending Increases Exponentially for Higher Standard of Breast Cancer Drug Treatments

    8:30 a.m. Today

    - PR Newswire - PRF

  5. Promising Developments in Breast Cancer Treatments Ahead in 2022

    10:58 a.m. Jan. 12, 2022

    - PR Newswire - PRF

  6. Promising Developments in Breast Cancer Treatments Ahead in 2022

    10:55 a.m. Jan. 12, 2022

    - Financial News Media

  7. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/202561856/composite MSTR-17.84%
  • /zigman2/quotes/205315244/composite DHT-4.09%
X
Powered by StockTwits
Link to MarketWatch's Slice.